银屑病综合治疗及护理效果观察被引量：2

导出

摘要目的:观察药物联合窄谱中波紫外线照射、中药浴治疗寻常型银屑病的临床疗效,探索银屑病综合护理的要点。方法:选取我院寻常型银屑病患者114例并随机分为观察组(69例)及对照组(45例),均采用药物联合窄谱中波紫外线照射、中药浴行综合治疗,观察组全程予综合护理,对照组则给予常规护理,观察两组临床疗效。结果:观察组总有效率达91.3%,显著高于对照组的71.1%(P<0.05)。结论:药物联合窄谱中波紫外线照射、中药浴治疗寻常型银屑病疗效显著,综合护理有助于提高治疗效果。

作者蒋丽娜

机构地区山东省菏泽市中医医院

出处《按摩与康复医学》 2019年第4期85-86,共2页 Chinese Manipulation and Rehabilitation Medicine

关键词寻常型银屑病药物治疗紫外线照射中药浴综合护理疗效

分类号 R473.75 [医药卫生—护理学]

引文网络
相关文献

参考文献7

1刘鹏月,韩秀萍.银屑病生物制剂治疗方法进展[J].临床皮肤科杂志,2017,46(11):820-823. 被引量：12
2许静芳,林贤娜,张璇君,李春香,章快芳.心理干预对银屑病患者焦虑抑郁情绪的影响[J].吉林医学,2015,36(4):747-748. 被引量：14
3赵国敏.260例寻常型银屑病患者的中医护理体会[J].中国麻风皮肤病杂志,2009,25(8):611-612. 被引量：6
4罗轶波,杨利蓉,王婷婷,陈吉辉.延续护理对银屑病患者的影响探究[J].中国地方病防治,2014,29(S2):308-309. 被引量：3
5鲁智勇,郑捷.银屑病病情严重程度的评价方法[J].诊断学理论与实践,2009,8(3):360-362. 被引量：38
6王爱燕,崔艳霞,张华梅,孙凤桂,孙通华.综合护理干预对改善寻常型银屑病患者焦虑抑郁状态的研究[J].中国社区医师,2016,32(24):147-148. 被引量：15
7甘永梅,蒋丽君,唐卫民,陈晓,韩志香.延续护理对银屑病病人的影响研究[J].护理研究（下旬版）,2013,27(12):4211-4211. 被引量：8

二级参考文献32

1刘宏,李霞,赵爱丽,孙丹,刘玉梅.慢性阻塞性肺疾病的延续护理效果研究[J].中国全科医学,2013,16(8):867-869. 被引量：55
2李玉华,胡英,谢继璜,李雪.80例重症银屑病患者的心理分析及护理干预[J].岭南皮肤性病科杂志,2006,13(2):174-175. 被引量：16
3Glade CP, van Erp PE, Boezeman JB, et al. Multiparameter flow eytometry as a tool to evaluate antipsoriatic therapy[J]. Br J Dermatol, 1997, 137(3):367-375.
4Piskin G, Heydendael VM, de Rie MA, et al. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN-gamma and IL-4 expression in psoriatic skin in situ[J]. Arch Dermatol Res, 2003, 294(12): 559-562.
5de Rie MA, Hamerlinck F, Hintzen RQ, et al. Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis[J]. Arch Dermatol Res, 1991, 283(8): 533-534.
6Borska L, Andrys C, Krejsek J, et al. Serum levels of the pro-inflammatory cytokine interleukin-12 and the antiinflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen[J]. Int J Dermatol, 2008, 47(8):800-805.
7Garduno J, Bhosle M J, Balkrishnan R, et al. Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review[J]. J Dermatolog Treat, 2007, 18(4):223-242.
8Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid[J]. Dermatologica, 1978, 157(4): 238-244.
9Krueger GG, Feldman SR, Camisa C, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?[J]. J Am Acad Dermatol, 2000, 43(2 Pt 1):281-285.
10Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The self-administered psoriasis area and severity index is valid and reliable[J]. J Invest Dermatol, 1996, 106(1): 183-186.